Lionheart Ventures is a venture capital firm dedicated to the advancement and responsible application of transformative technologies. With a strong focus on artificial intelligence (AI) and mental health technologies, the firm believes these sectors hold significant potential for fostering a better future for humanity. Exceptional, ethical founders with innovative ideas that can make a meaningful impact on society while offering attractive returns for investors are the primary targets for their investments. The firm is particularly concerned with the emergence of advanced AI, predicting it to be more disruptive than the Industrial Revolution. Lionheart Ventures is committed to investing in AI technologies that enhance human flourishing, agency, and resilience, as they believe this will help ensure a smooth transition into this new era. They also recognize the current mental health crisis and its impact on quality of life and decision making. In response, they invest in frontier technologies such as psychedelic medicine and neuromodulation to dramatically improve the current standard of care. As a team of former founders, Lionheart Ventures brings firsthand experience to their work, having raised funds from leading venture capital firms and successfully built and exited their own companies. Their narrow focus on AI and frontier mental health is deliberate, enabling them to make the most significant impact possible in these areas. They are supported by a network of expert advisors who help them develop a deep understanding of their focus areas. Lionheart Ventures prides itself on its values of intellectual honesty, ethical conduct, and counterfactual impact. They aim to lead conversations about responsible stewardship of humanity's most transformative technologies. Among the companies they back are Anthropic, a company specializing in general AI systems; Calm, a global health and wellness brand application designed to promote mental fitness and alleviate mental health issues; Encultured AI, a video game company focused on safely integrating AI technologies; and Reconnect Labs, a pharmaceutical company at the forefront of neuroscience and precision psychopharmacology.